Therapeutic Focus
A key focus of Mayne Pharma is to develop therapies and solutions that measurably improve individual’s lives. Mayne Pharma is focused on the following therapeutic areas to bring innovative products to clinicians, pharmacists and patients.
US
Women’s Health
Mayne Pharma strives to become the #1 Women’s Healthcare company through the lens of the patients we serve. Our products uniquely support women’s journey through reproductive health, supportive prenatal care and reduced symptoms related to peri and post menopause.
Dermatology: patient access for all
At Mayne Pharma, we are on a mission to ensure that patients have enhanced access to high-quality dermatology products.
We proudly offer a diverse range of medications, including branded and generic options, which are essential in treating conditions such as rosacea, acne, psoriasis, and atopic dermatitis.
Our unwavering commitment to providing patient access to quality medications is at the heart of everything we do. Through our dedication, we strive to improve health outcomes and enhance the quality of life for individuals facing dermatological challenges.
Australia
Women’s Health
Mayne Pharma strives to become the #1 Women’s Healthcare company through the lens of the patients we serve. Our products uniquely support women’s journey through reproductive health, supportive prenatal care and reduced symptoms related to peri and post menopause.
Dermatology: patient access for all
At Mayne Pharma, we are on a mission to ensure that patients have enhanced access to high-quality dermatology products.
We proudly offer a diverse range of medications, including branded and generic options, which are essential in treating conditions such as rosacea, acne, psoriasis, and atopic dermatitis.
Our unwavering commitment to providing patient access to quality medications is at the heart of everything we do. Through our dedication, we strive to improve health outcomes and enhance the quality of life for individuals facing dermatological challenges.
Infectious disease
Mayne Pharma’s patented SUBA® technology significantly increases the absorption of existing antifungal compounds allowing for equivalent treatment outcomes from reduced dose administration.
Pain
Mayne Pharma has developed and markets a range of analgesic products, including immediate and extended-release as well as single and combination products.
